138 related articles for article (PubMed ID: 33211000)
1. Predictors of renal outcomes in crescentic and mixed class of ANCA-associated glomerulonephritis.
You X; Zhang J; Ding X; Zhang J; Zhou Q; Lu G
Clin Nephrol; 2021 Feb; 95(2):81-86. PubMed ID: 33211000
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors.
Tanna A; Guarino L; Tam FW; Rodriquez-Cubillo B; Levy JB; Cairns TD; Griffith M; Tarzi RM; Caplin B; Salama AD; Cook T; Pusey CD
Nephrol Dial Transplant; 2015 Jul; 30(7):1185-92. PubMed ID: 25016608
[TBL] [Abstract][Full Text] [Related]
3. The predictive value of Berden's classification versus renal risk score for renal survival of Chinese patients with myeloperoxidase-anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
Kong W; Ni A; Wang M; Huang X; Chen L; Ma Y; Chen J; Han F
Clin Exp Rheumatol; 2023 Apr; 41(4):893-901. PubMed ID: 36762743
[TBL] [Abstract][Full Text] [Related]
4. Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody Glomerulonephritis.
Menez S; Hruskova Z; Scott J; Cormican S; Chen M; Salama AD; Alasfar S; Little MA; Safrankova H; Honsova E; Tesar V; Geetha D
Am J Nephrol; 2018; 48(6):465-471. PubMed ID: 30472700
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of the 2010 histopathological classification of anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis: a Bayesian network meta-analysis.
Huang S; Shen Q; Yang R; Lai H; Zhang J
Int Urol Nephrol; 2018 Oct; 50(10):1853-1861. PubMed ID: 30046964
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Clinico-pathologic features and outcomes of ANCA negative and ANCA positive pauci immune crescentic glomerulonephritis: A single centre study.
Gupta P; Bhargava V; Malik M; Gupta A; Bhalla AK; Gupta A; Tiwari V; Rana DS; Sapra RL
Indian J Pathol Microbiol; 2024; 67(1):86-91. PubMed ID: 38358194
[TBL] [Abstract][Full Text] [Related]
7. Poor renal outcomes in patients with anti-neutrophil cytoplasmic antibody-associated crescentic glomerulonephritis and normal renal function at diagnosis.
Hanaoka H; Ota Y; Takeuchi T; Kuwana M
Clin Rheumatol; 2016 Feb; 35(2):495-500. PubMed ID: 26742758
[TBL] [Abstract][Full Text] [Related]
8. Validation of the renal risk score for antineutrophil cytoplasmic antibody-associated glomerulonephritis in a Chinese population.
Bai X; Guo Q; Lou Y; Nie P; Zhu Y; Li B; Luo P
Clin Rheumatol; 2021 Dec; 40(12):5009-5017. PubMed ID: 34282511
[TBL] [Abstract][Full Text] [Related]
9. Modified histopathological classification with age-related glomerulosclerosis for predicting kidney survival in ANCA-associated glomerulonephritis.
Aydın MF; Yıldız A; Oruç A; Aytaç Vuruşkan B; Akgür S; Ayar Y; Güllülü M; Dilek K; Yavuz M; Ortaç H; Ersoy A
Int Urol Nephrol; 2023 Mar; 55(3):741-748. PubMed ID: 36153782
[TBL] [Abstract][Full Text] [Related]
10. The new histopathologic classification of ANCA-associated GN and its association with renal outcomes in childhood.
Noone DG; Twilt M; Hayes WN; Thorner PS; Benseler S; Laxer RM; Parekh RS; Hebert D
Clin J Am Soc Nephrol; 2014 Oct; 9(10):1684-91. PubMed ID: 25147157
[TBL] [Abstract][Full Text] [Related]
11. Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
Iwakiri T; Fujimoto S; Kitagawa K; Furuichi K; Yamahana J; Matsuura Y; Yamashita A; Uezono S; Shimao Y; Hisanaga S; Tokura T; Wada T; Kitamura K; Asada Y
BMC Nephrol; 2013 Jun; 14():125. PubMed ID: 23773275
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Factors Influencing Outcomes in Pauci-Immune Crescentic Glomerulonephritis: Single Centre Experience of 51 Cases.
Gupta P; Dharamdasani S; Gupta A; Bhalla AK; Gupta A; Malik M; Bhargava V; Tiwari V; Rana DS; Sapra RL
Indian J Nephrol; 2021; 31(6):503-506. PubMed ID: 35068754
[TBL] [Abstract][Full Text] [Related]
13. Risk factors affecting renal function and survival of patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis
.
Ge Y; Yang G; Yu X; Sun B; Zhang B; Zeng M; Wang N; Mao H; Xing C
Clin Nephrol; 2020 Aug; 94(2):78-85. PubMed ID: 32567543
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a renal risk score in ANCA-associated glomerulonephritis.
Brix SR; Noriega M; Tennstedt P; Vettorazzi E; Busch M; Nitschke M; Jabs WJ; Özcan F; Wendt R; Hausberg M; Sellin L; Panzer U; Huber TB; Waldherr R; Hopfer H; Stahl RAK; Wiech T
Kidney Int; 2018 Dec; 94(6):1177-1188. PubMed ID: 30385041
[TBL] [Abstract][Full Text] [Related]
15. Histopathological Classification-A Prognostic Tool for Rapidly Progressive Glomerulonephritis.
Kantauskaitė M; Laučytė-Cibulskienė A; Miglinas M
Medicina (Kaunas); 2018 Apr; 54(2):. PubMed ID: 30344248
[No Abstract] [Full Text] [Related]
16. Thirty years of experience with anti-neutrophil cytoplasmic antibody glomerulonephritis in Charles Nicolle Hospital-Tunisia: a retrospective cohort study.
Hajji M; Barbouch S; Goucha R; Hamida FB; Gorsane I; Abderrahim E
Pan Afr Med J; 2022; 42():84. PubMed ID: 36034042
[TBL] [Abstract][Full Text] [Related]
17. ANCA serotype and histopathological classification for the prediction of renal outcome in ANCA-associated glomerulonephritis.
Quintana LF; Peréz NS; De Sousa E; Rodas LM; Griffiths MH; Solé M; Jayne D
Nephrol Dial Transplant; 2014 Sep; 29(9):1764-9. PubMed ID: 24748668
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a renal risk score for Japanese patients with ANCA-associated glomerulonephritis in a multi-center cohort study.
Uchida T; Ichinose K; Yamashita A; Muta K; Kitamura M; Sato S; Iwamoto N; Nishino T; Kawakami A
Front Immunol; 2023; 14():1141407. PubMed ID: 36926340
[TBL] [Abstract][Full Text] [Related]
19. Novel histopathologic predictors for renal outcomes in crescentic glomerulonephritis.
Lim JH; Han MH; Kim YJ; Jeon Y; Jung HY; Choi JY; Cho JH; Kim CD; Kim YL; Lee H; Kim DK; Moon KC; Park SH
PLoS One; 2020; 15(7):e0236051. PubMed ID: 32716952
[TBL] [Abstract][Full Text] [Related]
20. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
